These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 19361894

  • 1. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
    Kumar V, Jaggi M, Singh AT, Madaan A, Sanna V, Singh P, Sharma PK, Irchhaiya R, Burman AC.
    Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
    [Abstract] [Full Text] [Related]

  • 2. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
    Kumar V, Madaan A, Sanna VK, Vishnoi M, Joshi N, Singh AT, Jaggi M, Sharma PK, Irchhaiya R, Burman AC.
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
    [Abstract] [Full Text] [Related]

  • 3. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
    Srivastava SK, Jaggi M, Singh AT, Madan A, Rani N, Vishnoi M, Agarwal SK, Mukherjee R, Burman AC.
    Bioorg Med Chem Lett; 2007 Dec 01; 17(23):6660-4. PubMed ID: 17950602
    [Abstract] [Full Text] [Related]

  • 4. 1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity.
    Roma G, Di Braccio M, Grossi G, Piras D, Ballabeni V, Tognolini M, Bertoni S, Barocelli E.
    Eur J Med Chem; 2010 Jan 01; 45(1):352-66. PubMed ID: 19913952
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones.
    Deady LW, Rogers ML, Zhuang L, Baguley BC, Denny WA.
    Bioorg Med Chem; 2005 Feb 15; 13(4):1341-55. PubMed ID: 15670942
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential.
    Madaan A, Kumar V, Verma R, Singh AT, Jain SK, Jaggi M.
    Int Immunopharmacol; 2013 Mar 15; 15(3):606-13. PubMed ID: 23370301
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
    Bandgar BP, Totre JV, Gawande SS, Khobragade CN, Warangkar SC, Kadam PD.
    Bioorg Med Chem; 2010 Aug 15; 18(16):6149-55. PubMed ID: 20638287
    [Abstract] [Full Text] [Related]

  • 8. 1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity.
    Roma G, Grossi G, Di Braccio M, Piras D, Ballabeni V, Tognolini M, Bertoni S, Barocelli E.
    Eur J Med Chem; 2008 Aug 15; 43(8):1665-80. PubMed ID: 18045747
    [Abstract] [Full Text] [Related]

  • 9. 1,8-Naphthyridines VI. Synthesis and anti-inflammatory activity of 5-(alkylamino)-N,N-diethyl[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides with a new substitution pattern on the triazole ring.
    Di Braccio M, Grossi G, Roma G, Piras D, Mattioli F, Gosmar M.
    Eur J Med Chem; 2008 Mar 15; 43(3):584-94. PubMed ID: 17602797
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines.
    Deady LW, Rodemann T, Zhuang L, Baguley BC, Denny WA.
    J Med Chem; 2003 Mar 13; 46(6):1049-54. PubMed ID: 12620081
    [Abstract] [Full Text] [Related]

  • 11. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
    Sondhi SM, Rani R, Singh J, Roy P, Agrawal SK, Saxena AK.
    Bioorg Med Chem Lett; 2010 Apr 01; 20(7):2306-10. PubMed ID: 20188544
    [Abstract] [Full Text] [Related]

  • 12. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.
    Manera C, Malfitano AM, Parkkari T, Lucchesi V, Carpi S, Fogli S, Bertini S, Laezza C, Ligresti A, Saccomanni G, Savinainen JR, Ciaglia E, Pisanti S, Gazzerro P, Di Marzo V, Nieri P, Macchia M, Bifulco M.
    Eur J Med Chem; 2015 Jun 05; 97():10-8. PubMed ID: 25935384
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
    Mastalarz H, Jasztold-Howorko R, Rulko F, Croisy A, Carrez D.
    Arch Pharm (Weinheim); 2004 Aug 05; 337(8):434-9. PubMed ID: 15293262
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
    Banti I, Nencetti S, Orlandini E, Lapucci A, Breschi MC, Fogli S.
    J Pharm Pharmacol; 2009 Aug 05; 61(8):1057-66. PubMed ID: 19703350
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, anti-inflammatory and anticancer activity evaluation of some novel acridine derivatives.
    Sondhi SM, Singh J, Rani R, Gupta PP, Agrawal SK, Saxena AK.
    Eur J Med Chem; 2010 Feb 05; 45(2):555-63. PubMed ID: 19926172
    [Abstract] [Full Text] [Related]

  • 16. Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines.
    Rudys S, Ríos-Luci C, Pérez-Roth E, Cikotiene I, Padrón JM.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1504-6. PubMed ID: 20144871
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
    Tsuzuki Y, Tomita K, Sato Y, Kashimoto S, Chiba K.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3189-93. PubMed ID: 15149673
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
    Tsuzuki Y, Tomita K, Shibamori K, Sato Y, Kashimoto S, Chiba K.
    J Med Chem; 2004 Apr 08; 47(8):2097-109. PubMed ID: 15056007
    [Abstract] [Full Text] [Related]

  • 19. Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.
    Bilodeau MT, Balitza AE, Hoffman JM, Manley PJ, Barnett SF, Defeo-Jones D, Haskell K, Jones RE, Leander K, Robinson RG, Smith AM, Huber HE, Hartman GD.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3178-82. PubMed ID: 18479914
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines.
    Chandrika PM, Yakaiah T, Rao AR, Narsaiah B, Reddy NC, Sridhar V, Rao JV.
    Eur J Med Chem; 2008 Apr 01; 43(4):846-52. PubMed ID: 17689837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.